We are live on ! Find out more
FPS

Fieldpoint Private Securities Portfolio holdings

AUM $344M
1-Year Est. Return 7.21%
This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
-7.21%
3 Year Est. Return
+47.17%
5 Year Est. Return
+78.97%
10 Year Est. Return
AUM
$344M
AUM Growth
-$141M
Cap. Flow
-$78.3M
Cap. Flow %
-22.73%
Top 10 Hldgs %
23.05%
Holding
1,793
New
93
Increased
202
Reduced
1,081
Closed
244

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.41%
2 Technology 15.14%
3 Financials 9.93%
4 Healthcare 9.62%
5 Industrials 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHK icon
351
Mohawk Industries
MHK
$9.05B
$107K 0.03%
866
-13
-1% -$1.73K
CRWD icon
352
CrowdStrike
CRWD
$218B
$105K 0.03%
2,484
+460
+23% +$20.8K
DLB icon
353
Dolby
DLB
$5.8B
$105K 0.03%
1,473
-3
-0.2% -$227
STT icon
354
State Street
STT
$53.4B
$105K 0.03%
1,711
-968
-36% -$68.5K
FFIC
355
DELISTED
Flushing Financial
FFIC
$104K 0.03%
4,911
PRU icon
356
Prudential Financial
PRU
$42.1B
$104K 0.03%
1,087
+122
+13% +$12.9K
TIPZ icon
357
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.3M
$104K 0.03%
1,800
USCB icon
358
USCB Financial Holdings
USCB
$434M
$104K 0.03%
9,000
+7,000
+350% +$92.7K
TLT icon
359
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
$103K 0.03%
896
-4,397
-83% -$518K
VPL icon
360
Vanguard FTSE Pacific ETF
VPL
$8.79B
$103K 0.03%
1,625
XAR icon
361
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.77B
$103K 0.03%
1,020
MDB icon
362
MongoDB
MDB
$29.7B
$102K 0.03%
393
NBIX icon
363
Neurocrine Biosciences
NBIX
$15.8B
$102K 0.03%
1,046
-42
-4% -$3.88K
ED icon
364
Consolidated Edison
ED
$39.7B
$101K 0.03%
1,066
-60
-5% -$5.71K
JCI icon
365
Johnson Controls International
JCI
$87.8B
$101K 0.03%
2,117
-292
-12% -$16.3K
NFG icon
366
National Fuel Gas
NFG
$7.92B
$101K 0.03%
1,525
-205
-12% -$14.4K
SAP icon
367
SAP
SAP
$248B
$101K 0.03%
1,117
+492
+79% +$49.2K
TMUS icon
368
T-Mobile US
TMUS
$195B
$100K 0.03%
741
+169
+30% +$22.1K
ARWR icon
369
Arrowhead Research
ARWR
$12.2B
$99K 0.03%
2,804
-179
-6% -$6.73K
ZBH icon
370
Zimmer Biomet
ZBH
$18.7B
$99K 0.03%
945
-45
-5% -$5.34K
AMP icon
371
Ameriprise Financial
AMP
$49.5B
$98K 0.03%
414
+301
+266% +$80.6K
WBA
372
DELISTED
Walgreens Boots Alliance
WBA
$98K 0.03%
2,575
+144
+6% +$6.19K
VBK icon
373
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.9B
$97K 0.03%
491
+35
+8% +$7.59K
BMRN icon
374
BioMarin Pharmaceuticals
BMRN
$12.9B
$96K 0.03%
1,155
-3
-0.3% -$239
NYT icon
375
New York Times
NYT
$10.9B
$96K 0.03%
3,431
-68
-2% -$2.46K

Similar funds

Fieldpoint Private Securities's Q2 2022 Portfolio in Review

As of Q2 2022, Fieldpoint Private Securities held 1,793 positions worth $344M, down 29% from $485M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Fieldpoint Private Securities withdrew a net $78.3M in Q2 2022, closing 244 positions and reducing 1,081 holdings. Its most notable exit was State Street SPDR S&P Dividend ETF, an estimated $911K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 36% a quarter earlier, followed by Technology and Financials.

Against the trend, Fieldpoint Private Securities opened a new position in WisdomTree US MidCap Dividend Fund worth $3.48M.

  • Fieldpoint Private Securities's largest Q2 2022 buy was WisdomTree US MidCap Dividend Fund: 89,302 shares worth $3.48M.
  • Fieldpoint Private Securities added most to iShares International Select Dividend ETF in Q2 2022, an estimated $7M increase.
  • Fieldpoint Private Securities's biggest Q2 2022 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.61M.
  • Fieldpoint Private Securities fully exited State Street SPDR S&P Dividend ETF in Q2 2022, selling an estimated $911K.
  • Fieldpoint Private Securities's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
  • Fieldpoint Private Securities opened 93 new positions and closed 244 in Q2 2022.
  • Fieldpoint Private Securities's portfolio value fell 29% quarter-over-quarter to $344M.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.